nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC6A4—chronic obstructive pulmonary disease	0.125	0.523	CbGaD
Dopamine—CYP1A2—chronic obstructive pulmonary disease	0.114	0.477	CbGaD
Dopamine—Dobutamine—Arformoterol—chronic obstructive pulmonary disease	0.0787	0.189	CrCrCtD
Dopamine—Dobutamine—Formoterol—chronic obstructive pulmonary disease	0.0787	0.189	CrCrCtD
Dopamine—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0502	0.193	CbGbCtD
Dopamine—Isoetarine—Salbutamol—chronic obstructive pulmonary disease	0.0462	0.111	CrCrCtD
Dopamine—Norepinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0431	0.104	CrCrCtD
Dopamine—Levonordefrin—Salbutamol—chronic obstructive pulmonary disease	0.0405	0.0971	CrCrCtD
Dopamine—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0381	0.146	CbGbCtD
Dopamine—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0381	0.146	CbGbCtD
Dopamine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0361	0.139	CbGbCtD
Dopamine—Isoprenaline—Arformoterol—chronic obstructive pulmonary disease	0.035	0.0841	CrCrCtD
Dopamine—Isoprenaline—Formoterol—chronic obstructive pulmonary disease	0.035	0.0841	CrCrCtD
Dopamine—Epinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0326	0.0784	CrCrCtD
Dopamine—Isoprenaline—Salbutamol—chronic obstructive pulmonary disease	0.0266	0.0638	CrCrCtD
Dopamine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0127	0.0489	CbGbCtD
Dopamine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0127	0.0489	CbGbCtD
Dopamine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0106	0.0407	CbGbCtD
Dopamine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0106	0.0407	CbGbCtD
Dopamine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.01	0.0384	CbGbCtD
Dopamine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00969	0.0372	CbGbCtD
Dopamine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00969	0.0372	CbGbCtD
Dopamine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00864	0.0331	CbGbCtD
Dopamine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.00803	0.0308	CbGbCtD
Dopamine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00535	0.0205	CbGbCtD
Dopamine—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00187	0.152	CbGeAlD
Dopamine—Ventricular arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.0523	CcSEcCtD
Dopamine—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.046	CcSEcCtD
Dopamine—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.0445	CcSEcCtD
Dopamine—Extravasation—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.0444	CcSEcCtD
Dopamine—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.000844	0.035	CcSEcCtD
Dopamine—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.000844	0.035	CcSEcCtD
Dopamine—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.000797	0.0331	CcSEcCtD
Dopamine—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.000714	0.0297	CcSEcCtD
Dopamine—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.0226	CcSEcCtD
Dopamine—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.000544	0.0226	CcSEcCtD
Dopamine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00054	0.0224	CcSEcCtD
Dopamine—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.000538	0.0223	CcSEcCtD
Dopamine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000519	0.0215	CcSEcCtD
Dopamine—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.0213	CcSEcCtD
Dopamine—COMT—respiratory system—chronic obstructive pulmonary disease	0.000453	0.0368	CbGeAlD
Dopamine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.018	CcSEcCtD
Dopamine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000434	0.018	CcSEcCtD
Dopamine—Isoetarine—ADRB2—chronic obstructive pulmonary disease	0.000419	0.18	CrCbGaD
Dopamine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.017	CcSEcCtD
Dopamine—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.000404	0.0329	CbGeAlD
Dopamine—COMT—bronchus—chronic obstructive pulmonary disease	0.000373	0.0303	CbGeAlD
Dopamine—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000371	0.0301	CbGeAlD
Dopamine—COMT—smooth muscle tissue—chronic obstructive pulmonary disease	0.000365	0.0297	CbGeAlD
Dopamine—Mesalazine—MPO—chronic obstructive pulmonary disease	0.000363	0.156	CrCbGaD
Dopamine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.015	CcSEcCtD
Dopamine—Necrosis—Prednisone—chronic obstructive pulmonary disease	0.000356	0.0148	CcSEcCtD
Dopamine—MAOB—respiratory system—chronic obstructive pulmonary disease	0.000352	0.0287	CbGeAlD
Dopamine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000346	0.0144	CcSEcCtD
Dopamine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.0141	CcSEcCtD
Dopamine—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000338	0.0275	CbGeAlD
Dopamine—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.000335	0.0273	CbGeAlD
Dopamine—COMT—trachea—chronic obstructive pulmonary disease	0.000335	0.0272	CbGeAlD
Dopamine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000332	0.0138	CcSEcCtD
Dopamine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000326	0.0265	CbGeAlD
Dopamine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.0135	CcSEcCtD
Dopamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000317	0.0132	CcSEcCtD
Dopamine—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000316	0.0257	CbGeAlD
Dopamine—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000314	0.0256	CbGeAlD
Dopamine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000313	0.013	CcSEcCtD
Dopamine—MAOB—connective tissue—chronic obstructive pulmonary disease	0.00031	0.0252	CbGeAlD
Dopamine—Dobutamine—ADRB2—chronic obstructive pulmonary disease	0.000307	0.132	CrCbGaD
Dopamine—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000307	0.0249	CbGeAlD
Dopamine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000306	0.0127	CcSEcCtD
Dopamine—MAOA—respiratory system—chronic obstructive pulmonary disease	0.000301	0.0244	CbGeAlD
Dopamine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000297	0.0242	CbGeAlD
Dopamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000296	0.0123	CcSEcCtD
Dopamine—MAOB—bronchus—chronic obstructive pulmonary disease	0.00029	0.0236	CbGeAlD
Dopamine—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.000277	0.0225	CbGeAlD
Dopamine—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000277	0.0225	CbGeAlD
Dopamine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.0114	CcSEcCtD
Dopamine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000274	0.0114	CcSEcCtD
Dopamine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000269	0.0112	CcSEcCtD
Dopamine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.0111	CcSEcCtD
Dopamine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000268	0.0111	CcSEcCtD
Dopamine—MAOA—connective tissue—chronic obstructive pulmonary disease	0.000265	0.0215	CbGeAlD
Dopamine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000263	0.0109	CcSEcCtD
Dopamine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.0109	CcSEcCtD
Dopamine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.0108	CcSEcCtD
Dopamine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000258	0.0107	CcSEcCtD
Dopamine—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000253	0.0206	CbGeAlD
Dopamine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.0105	CcSEcCtD
Dopamine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000251	0.0204	CbGeAlD
Dopamine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.0103	CcSEcCtD
Dopamine—MAOA—bronchus—chronic obstructive pulmonary disease	0.000247	0.0201	CbGeAlD
Dopamine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.0103	CcSEcCtD
Dopamine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.0103	CcSEcCtD
Dopamine—COMT—lung—chronic obstructive pulmonary disease	0.00024	0.0196	CbGeAlD
Dopamine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00969	CcSEcCtD
Dopamine—HTR7—trachea—chronic obstructive pulmonary disease	0.000232	0.0189	CbGeAlD
Dopamine—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000228	0.0185	CbGeAlD
Dopamine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00937	CcSEcCtD
Dopamine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00937	CcSEcCtD
Dopamine—MAOA—trachea—chronic obstructive pulmonary disease	0.000222	0.0181	CbGeAlD
Dopamine—SLC6A3—lung—chronic obstructive pulmonary disease	0.000215	0.0175	CbGeAlD
Dopamine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00885	CcSEcCtD
Dopamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00878	CcSEcCtD
Dopamine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000208	0.00865	CcSEcCtD
Dopamine—SLC22A5—trachea—chronic obstructive pulmonary disease	0.000205	0.0166	CbGeAlD
Dopamine—ADRB1—lung—chronic obstructive pulmonary disease	0.000204	0.0166	CbGeAlD
Dopamine—SLC22A3—lung—chronic obstructive pulmonary disease	0.000202	0.0164	CbGeAlD
Dopamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00828	CcSEcCtD
Dopamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.00821	CcSEcCtD
Dopamine—SLC6A4—lung—chronic obstructive pulmonary disease	0.000197	0.016	CbGeAlD
Dopamine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.00816	CcSEcCtD
Dopamine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00816	CcSEcCtD
Dopamine—Droxidopa—ADRB2—chronic obstructive pulmonary disease	0.000191	0.0822	CrCbGaD
Dopamine—MAOB—lung—chronic obstructive pulmonary disease	0.000187	0.0152	CbGeAlD
Dopamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.00774	CcSEcCtD
Dopamine—Isoprenaline—ADRB2—chronic obstructive pulmonary disease	0.000174	0.0747	CrCbGaD
Dopamine—SLC6A2—lung—chronic obstructive pulmonary disease	0.000173	0.0141	CbGeAlD
Dopamine—HTR7—lung—chronic obstructive pulmonary disease	0.000167	0.0136	CbGeAlD
Dopamine—Epinephrine—TNF—chronic obstructive pulmonary disease	0.000165	0.0708	CrCbGaD
Dopamine—Norepinephrine—ADRB2—chronic obstructive pulmonary disease	0.000161	0.0692	CrCbGaD
Dopamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00669	CcSEcCtD
Dopamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00669	CcSEcCtD
Dopamine—MAOA—lung—chronic obstructive pulmonary disease	0.00016	0.013	CbGeAlD
Dopamine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00659	CcSEcCtD
Dopamine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00659	CcSEcCtD
Dopamine—DRD2—lung—chronic obstructive pulmonary disease	0.000158	0.0128	CbGeAlD
Dopamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00655	CcSEcCtD
Dopamine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00645	CcSEcCtD
Dopamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00631	CcSEcCtD
Dopamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00625	CcSEcCtD
Dopamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00625	CcSEcCtD
Dopamine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00622	CcSEcCtD
Dopamine—Isoprenaline—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.064	CrCbGaD
Dopamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00612	CcSEcCtD
Dopamine—SLC22A5—lung—chronic obstructive pulmonary disease	0.000147	0.012	CbGeAlD
Dopamine—Epinephrine—ADRB2—chronic obstructive pulmonary disease	0.000146	0.0628	CrCbGaD
Dopamine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.00602	CcSEcCtD
Dopamine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00593	CcSEcCtD
Dopamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.0059	CcSEcCtD
Dopamine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.00556	CcSEcCtD
Dopamine—Norepinephrine—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.0572	CrCbGaD
Dopamine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000133	0.0108	CbGeAlD
Dopamine—Epinephrine—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.0519	CrCbGaD
Dopamine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00438	CcSEcCtD
Dopamine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000104	0.0043	CcSEcCtD
Dopamine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.00404	CcSEcCtD
Dopamine—Headache—Prednisolone—chronic obstructive pulmonary disease	8.59e-05	0.00357	CcSEcCtD
Dopamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.15e-05	0.00338	CcSEcCtD
Dopamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.00263	CcSEcCtD
Dopamine—Headache—Prednisone—chronic obstructive pulmonary disease	6.24e-05	0.00259	CcSEcCtD
Dopamine—Nausea—Prednisone—chronic obstructive pulmonary disease	5.92e-05	0.00246	CcSEcCtD
Dopamine—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.64e-06	0.00017	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.63e-06	0.000169	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.62e-06	0.000169	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.59e-06	0.000168	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.55e-06	0.000168	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.47e-06	0.000166	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.46e-06	0.000166	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	7.38e-06	0.000164	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.34e-06	0.000163	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.34e-06	0.000163	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.31e-06	0.000162	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.31e-06	0.000162	CbGpPWpGaD
Dopamine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.25e-06	0.000161	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.25e-06	0.000161	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.19e-06	0.00016	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.18e-06	0.000159	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.13e-06	0.000158	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.02e-06	0.000156	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.02e-06	0.000156	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.02e-06	0.000156	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.96e-06	0.000155	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.94e-06	0.000154	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.88e-06	0.000153	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.86e-06	0.000152	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.8e-06	0.000151	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.79e-06	0.000151	CbGpPWpGaD
Dopamine—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.78e-06	0.000151	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.77e-06	0.00015	CbGpPWpGaD
Dopamine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.76e-06	0.00015	CbGpPWpGaD
Dopamine—COMT—Metabolism—ALB—chronic obstructive pulmonary disease	6.75e-06	0.00015	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.71e-06	0.000149	CbGpPWpGaD
Dopamine—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.69e-06	0.000149	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.66e-06	0.000148	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.64e-06	0.000147	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	6.61e-06	0.000147	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.48e-06	0.000144	CbGpPWpGaD
Dopamine—COMT—Metabolism—NOS3—chronic obstructive pulmonary disease	6.46e-06	0.000143	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.42e-06	0.000143	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.41e-06	0.000142	CbGpPWpGaD
Dopamine—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	6.4e-06	0.000142	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.38e-06	0.000142	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.32e-06	0.00014	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.28e-06	0.000139	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.24e-06	0.000138	CbGpPWpGaD
Dopamine—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.23e-06	0.000138	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.14e-06	0.000136	CbGpPWpGaD
Dopamine—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.12e-06	0.000136	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.11e-06	0.000136	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.09e-06	0.000135	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.05e-06	0.000134	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.91e-06	0.000131	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.85e-06	0.00013	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.83e-06	0.00013	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.83e-06	0.00013	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.83e-06	0.000129	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.79e-06	0.000129	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.76e-06	0.000128	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.74e-06	0.000127	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.73e-06	0.000127	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.68e-06	0.000126	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.66e-06	0.000126	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.53e-06	0.000123	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.5e-06	0.000122	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.44e-06	0.000121	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	5.42e-06	0.00012	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.35e-06	0.000119	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.3e-06	0.000118	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.29e-06	0.000118	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.27e-06	0.000117	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.27e-06	0.000117	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.26e-06	0.000117	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.25e-06	0.000117	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.25e-06	0.000116	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.24e-06	0.000116	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.21e-06	0.000116	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.18e-06	0.000115	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	5.18e-06	0.000115	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.14e-06	0.000114	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.13e-06	0.000114	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.07e-06	0.000112	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.02e-06	0.000111	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.01e-06	0.000111	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5e-06	0.000111	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.92e-06	0.000109	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.91e-06	0.000109	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.89e-06	0.000109	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.78e-06	0.000106	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.77e-06	0.000106	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.77e-06	0.000106	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.74e-06	0.000105	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.72e-06	0.000105	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.71e-06	0.000105	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.71e-06	0.000104	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.69e-06	0.000104	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.68e-06	0.000104	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.66e-06	0.000103	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.63e-06	0.000103	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	4.58e-06	0.000102	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.56e-06	0.000101	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.52e-06	0.0001	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.5e-06	9.99e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.48e-06	9.95e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.4e-06	9.78e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.29e-06	9.52e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.27e-06	9.48e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.26e-06	9.46e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.26e-06	9.46e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.24e-06	9.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.24e-06	9.41e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.22e-06	9.38e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.21e-06	9.35e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.18e-06	9.29e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	4.18e-06	9.28e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	4.18e-06	9.27e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.1e-06	9.11e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.1e-06	9.1e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.07e-06	9.05e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.05e-06	8.98e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.03e-06	8.95e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	4.02e-06	8.92e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.97e-06	8.8e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.94e-06	8.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.92e-06	8.71e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.89e-06	8.64e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.87e-06	8.6e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.86e-06	8.57e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.85e-06	8.55e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.84e-06	8.53e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	3.84e-06	8.53e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.84e-06	8.52e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.81e-06	8.46e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.81e-06	8.46e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.7e-06	8.21e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.69e-06	8.18e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.65e-06	8.09e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.61e-06	8.01e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.6e-06	8e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.58e-06	7.94e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.57e-06	7.92e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.54e-06	7.86e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.53e-06	7.83e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.51e-06	7.79e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.49e-06	7.74e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.44e-06	7.65e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.44e-06	7.64e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.44e-06	7.64e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.4e-06	7.54e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.33e-06	7.39e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.33e-06	7.39e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.28e-06	7.29e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.27e-06	7.26e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.26e-06	7.23e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.25e-06	7.22e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.21e-06	7.13e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.2e-06	7.11e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.18e-06	7.05e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.17e-06	7.03e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.17e-06	7.03e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.16e-06	7.02e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.13e-06	6.96e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.13e-06	6.96e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.13e-06	6.95e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.11e-06	6.9e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.1e-06	6.88e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.03e-06	6.73e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3e-06	6.66e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.99e-06	6.64e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.98e-06	6.61e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.96e-06	6.57e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.95e-06	6.56e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.95e-06	6.55e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.93e-06	6.5e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.91e-06	6.47e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.89e-06	6.41e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.86e-06	6.35e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.86e-06	6.34e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.83e-06	6.29e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.82e-06	6.26e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.8e-06	6.21e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.78e-06	6.17e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.73e-06	6.06e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.71e-06	6.03e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.69e-06	5.97e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.68e-06	5.95e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.66e-06	5.9e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.64e-06	5.87e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.63e-06	5.84e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.6e-06	5.78e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.57e-06	5.71e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.55e-06	5.66e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.55e-06	5.66e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.54e-06	5.64e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.53e-06	5.62e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.51e-06	5.58e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.51e-06	5.58e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.5e-06	5.56e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.47e-06	5.48e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.44e-06	5.41e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.42e-06	5.38e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.41e-06	5.35e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.4e-06	5.32e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.39e-06	5.31e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.38e-06	5.29e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.33e-06	5.18e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.3e-06	5.12e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.3e-06	5.11e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.29e-06	5.09e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.29e-06	5.08e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.29e-06	5.08e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.26e-06	5.01e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.19e-06	4.87e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.18e-06	4.84e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.13e-06	4.72e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.1e-06	4.66e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.07e-06	4.6e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.06e-06	4.57e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.06e-06	4.57e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.03e-06	4.51e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.02e-06	4.49e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.01e-06	4.45e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.97e-06	4.37e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.92e-06	4.27e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.92e-06	4.26e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.9e-06	4.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.89e-06	4.19e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.85e-06	4.11e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.84e-06	4.08e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.82e-06	4.04e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.81e-06	4.01e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.77e-06	3.93e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.76e-06	3.9e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.75e-06	3.88e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.73e-06	3.85e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.73e-06	3.84e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.73e-06	3.84e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.71e-06	3.79e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.67e-06	3.71e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.66e-06	3.68e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.59e-06	3.52e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.58e-06	3.51e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.56e-06	3.47e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.55e-06	3.45e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.55e-06	3.45e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.49e-06	3.3e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.48e-06	3.29e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.42e-06	3.16e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.42e-06	3.15e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.36e-06	3.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.31e-06	2.9e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.19e-06	2.65e-05	CbGpPWpGaD
